Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma

NCT02249702 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Leiomyosarcoma

Interventions

DRUG: gemcitabine + docetaxel
DRUG: trabectedin

Sponsor

Mario Negri Institute for Pharmacological Research

Collaborators

[object Object]